MedTrace Logo

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

NCT05734989 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 248

Last updated 2026-04-24

Study results available
· View outcomes & findings →

Summary

In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP.

In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating Hispanic and Black patients with diabetes.

Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) and Black patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.

Conditions

Interventions

DIAGNOSTIC_TEST

HbA1c

HbA1c will screen to identify patients with Type 2 diabetes

BEHAVIORAL

PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD

Guidelines will be developed and provided to PCPs to use with their Hispanic/Latinx patients with or at risk for CKD.

DIAGNOSTIC_TEST

BP

Blood pressure measurements and HbA1c tests will be conducted to identify participants with or at risk for high blood pressure and/or Type 2 Diabetes. Those identified will be referred to PCP for follow up/treatment.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • Matthew Sinclair, MD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-18
Primary Completion
2025-04-04
Completion
2025-04-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05734989 on ClinicalTrials.gov